Drugs / Inflammatory skin disease formula
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05295979 | Mar 2023 → Feb 2024 | psoriasis | Chinese University of Hong Kong | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inflammatory skin disease formula | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05295979 ↗ |
| Known as | ISDF | “A Chinese medicine formula "Inflammatory skin disease formula (ISDF)" was prescribed by Prof. Lin for many years and observed to be effective in relieving atopic dermatitis and...” NCT05295979 ↗ |
| Action | Inhibit | “via inhibition of inflammation through inactivation of NF-κB p65 pathway” NCT05295979 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “A Chinese medicine formula "Inflammatory skin disease formula (ISDF)" was prescribed by Prof. Lin for many years” NCT05295979 ↗ |